Silo Pharma SILO
NASDAQ SILO
$1.50 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Silo Pharma (SILO) Asset Writedowns and Impairment (2020 - 2026)

Updated

Silo Pharma (SILO) reported Asset Writedowns and Impairment of $29,911 for Q1 2026.

Analysis

Silo Pharma (SILO) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

For FY2025, Silo Pharma posted Asset Writedowns and Impairment of $39,916.

  • Asset Writedowns and Impairment has a five-year compound annual growth rate of -22.0% (FY2020 to FY2025).
  • The Q1 2026 figure ranks as the highest quarterly Asset Writedowns and Impairment since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Silo Pharma 1.69 Mn 1.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 29,911.00
Dec 31, 2020 118,068.00
API Access

Silo Pharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=SILO&period=max&api_key=YOUR_API_KEY